Abstract
Non-enzymatic glycation can produce advanced glycation end products (AGEs), inducing a series of diabetic complications. In this study, oleanolic acid (OA) was found to inhibit the formation of fructosamine and α-dicarbonyl compounds, while AGEs was almost suppressed by OA at the concentration of 500 μg/mL. Moreover, OA exhibited strong anti-fibrillation and antioxidant abilities. It decreased the production of dityrosine, N′- formylkynurenine and kynurenine with strong ·OH and O2·− scavenging capacities. The binding of OA with lysine and arginine of bovine serum albumin (BSA) prevented BSA from the attack of sugars. The C−12 in the C ring of OA was predicted to trap methylglyoxal (MGO), forming the OA−MGO adduct. The antioxidant and MGO trapping abilities together with the secondary structure protection may be the main mechanism of anti-glycation ability of OA. These findings suggest that foods rich in OA are promising sources of anti-glycation agents. The study also provides a theoretical basis for the further functional research of OA in the prevention and treatment of diabetic complications.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
